Ascelia Pharma Announces Acceptance of Orviglance Data for Oral Presentation at the Annual Radiology Congress ESGAR 2026 [Yahoo! Finance]
Nasdaq, Inc. (NDAQ)
Last nasdaq, inc. earnings: 4/22 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.nasdaq.com
Company Research
Source: Yahoo! Finance
the life of people living with rare cancer conditions, today announced that an abstract with an evaluation of the detection of focal liver lesions with Orviglance contrast agent from two phase 2 studies has been accepted for oral presentation at the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Annual Meeting, taking place 9-12 June in Montpellier, France. The abstract titled "Diagnostic Value of Manganese-Based Contrast Agent (ACE-MBCA) vs Unenhanced MRI in Liver Lesion Detection: Re-analysis of STAR Study Images from Two Phase II Clinical Trials", demonstrated that Orviglance significantly improves the detection of focal liver lesions compared to unenhanced MRI. The findings underline the potential of Orviglance as a new contrast agent for liver MRI. "We are excited that an abstract with Orviglance data has been selected for oral presentation at ESGAR, one of the leading global forums for innovation in gastrointestinal and abdominal imaging. This recogniti
Show less
Read more
Impact Snapshot
Event Time:
NDAQ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NDAQ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NDAQ alerts
High impacting Nasdaq, Inc. news events
Weekly update
A roundup of the hottest topics
NDAQ
News
- Anti-Cancer MAbS Market Report 2026-2030 Featuring Strategic Analysis of Amgen, Bristol Myers Squibb Company, Eli Lilly and Company, Roche, GlaxoSmithKline and Other Key Players [Yahoo! Finance]Yahoo! Finance
- Mount Sinai and Guyana Ministry of Health Launch National Initiative to Strengthen Hospital Quality and Patient Safety [Yahoo! Finance]Yahoo! Finance
- Black Rock Coffee Bar Continues Expansion in Colorado with New Colorado Springs Location [Yahoo! Finance]Yahoo! Finance
- TUK Group Advances $20 Million Toronto Development Pipeline and Expands Peterborough Portfolio [Yahoo! Finance]Yahoo! Finance
- Case IH Celebrates American Farmers At The White House [Yahoo! Finance]Yahoo! Finance
NDAQ
Earnings
- 1/29/26 - Beat
NDAQ
Sec Filings
- 3/27/26 - Form SCHEDULE
- 3/13/26 - Form 4
- 3/10/26 - Form 4
- NDAQ's page on the SEC website